CMS Qualifies MedCurrent OrderWise® Clinical Decision Support Mechanism (CDSM) for Appropriate Use of Advanced Diagnostic Imaging

Share Article

CMS qualifies MedCurrent OrderWise® Clinical Decision Support Mechanism (CDSM) under the Appropriate Use Criteria (AUC) Program to enable real-time, evidence-based guidance for ordering advanced diagnostic imaging.

MedCurrent Corporation

Our new status represents a significant milestone on our journey to continuous innovation of our CDS offering and enabling clients to improve outcomes.

MedCurrent, a global leader in innovative healthcare IT solutions, has received full qualification by the Centers for Medicare and Medicaid Services (CMS) for its clinical decision support mechanism (CDSM), OrderWise®. Through this qualification, OrderWise® is recognized for establishing technology and processes to support healthcare providers improve the quality of patient care, manage costs and meet regulatory requirements for the appropriate use of advanced imaging.

Starting January 1, 2020, Medicare outpatient reimbursement for advanced diagnostic imaging procedures (MR, CT, NM, PET) will be at risk if ordering providers do not consult clinical decision support (CDS) as initially set forth in the Protecting Access to Medicare Act (PAMA, 2014). To meet the requirements of this mandate, only qualified CDSMs and Appropriate Use Criteria (AUC) developed by qualified provider-led entities (qPLEs) may be used.

“We are pleased to receive full qualification by attesting to the standards set forth by CMS. This is an opportunity to support healthcare providers in the US make evidence-based decisions for their patients,” says John Adziovsky, Chief Executive Officer (CEO), MedCurrent. “Our new status represents a significant milestone on our journey to continuous innovation of our CDS offering and enabling clients to improve outcomes.”

MedCurrent’s OrderWise® guides providers through clinical decision pathways to help them order the right imaging test for their patient. The solution is complemented by robust Analytics and Authoring Studio modules to support quality improvement initiatives and system customization. In the US, OrderWise® integrates imaging AUC from Intermountain Healthcare, Sage Evidence-based Medicine & Practice Institute (SEMPI), National Comprehensive Cancer Network (NCCN) and the American College of Cardiology (ACC). Internationally, OrderWise® now runs with the eighth edition of iRefer: Making the best use of clinical radiology, the most up-to-date referral guidance from The Royal College of Radiologists (RCR).

For more information on the AUC program and qualified CDSMs, please visit the Centers for Medicare and Medicaid Services (CMS).

About MedCurrent
MedCurrent is a physician-founded Clinical Decision Support (CDS) company focused on improving the quality of care and managing health system costs through our innovative and scalable solution, OrderWise. Our solution enhances the clinical decision-making process with real-time, evidence-based guidelines integrated at the point of care to improve health and healthcare delivery. Deep healthcare experience, superior technology and business agility make MedCurrent a global leader in CDS solutions. More information about MedCurrent is available at

Further information:
Hasan Dharamshi, VP Professional Services
1.855.279.3380 ext. 503

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Hasan Dharamshi
MedCurrent Corporation
+1 8552793380 Ext: 503
Email >
Visit website